J Cerebrovasc Endovasc Neurosurg > Epub ahead of print
Levinson, Pendharkar, Gauden, and Pulli: Radial artery access with a sheathless 0.087” inner diameter balloon guide catheter (Walrus) for neurointerventional procedures: Technique and clinical outcomes

Abstract

Intro

There is a growing preference among neurointerventionalists for transradial access (TRA) over transfemoral access (TFA) due to improved patient satisfaction, recovery time and reduced access site complication, but using balloon guide catheters (BGCs) in the radial artery remains a challenge. We report our experience in successfully using the 0.087” inner diameter Walrus BGC without a sheath via the radial artery for non-emergent neurointerventions.

Objective

Describe the technique for safely accessing the radial artery using the sheathless Walrus balloon guide catheter

Methods

A retrospective chart review of thirteen consecutive patients who underwent intervention with radial artery access with a sheathless Walrus BGC was performed.

Results

All twelve procedures were performed successfully with no instances of conversion from TRA to TFA. There were no significant procedural or access site complications. The mean radial diameter was 2.51 mm.

Conclusions

The Walrus 0.087” ID BGC is an effective tool that can safely be used via the radial artery using a sheathless approach, which helps to maximize the size of the catheter that can be used. This is the first instance of our knowledge of this technique being utilized for neurointerventions and therefore could be used to expand the indications for TRA for a wider range of procedures.

INTRODUCTION

There is a growing preference among neurointerventionalists for transradial access (TRA) over transfemoral access (TFA). This shift is driven by evidence suggesting that TRA enhances patient satisfaction, enables early ambulation, and reduces access site complications, aligning with trends in interventional cardiology [1,2,9]. Several case series have demonstrated the safety and effectiveness of TRA for various neurointerventions, including aneurysm coiling, flow diverting stent placement, and diagnostic cerebral angiography [4,17,20].
However, using large bore catheters commonly used in neurointerventional procedures can be challenging considering the smaller size of the radial artery compared to the common femoral artery. This is especially true for balloon guide catheters (BGCs) that require 8 or even 9-french sheaths. The outer diameter of these sheaths is larger than the size of the average radial artery (estimated at 2.68±0.24 mm in adult males and 2.27±0.27 in adult females) [22], and such size relationship has been found to correlate with post-procedure radial artery occlusion [8]. This may in part explain the approximately 10% crossover rate from transradial to transfemoral in a recent randomized trial of carotid stenting [22]. Hence, it seems advantageous to minimize device size for transradial interventions. Previously, Dossani et al. [7] published a case series where they used the Walrus BGC (Q’Apel Medical, Fremont, California, USA) without an additional sheath in acute ischemic stroke patients treated with thrombectomy. In this report, we expand on their findings by reporting on our experience using this BGC sheathless for neurointerventional procedures other than thrombectomy in which BGC use and TRA may have favorable characteristics (e.g., proximal flow-arrest to minimize thrombo-embolic events, and reduced access site complications in patients on antiplatelet medications).

METHODS

Patient population and data collection

We performed a retrospective chart review that identified thirteen consecutive patients who underwent non-emergent treatment of symptomatic cervical or intracranial carotid artery stenosis, or traumatic carotid artery injury via a sheathless transradial approach with the Walrus BGC at our institution between March 2023 and February 2024. All data were obtained and processed in accordance with an institution data and safety protocol (IRB# 37209).
We collected data on patient demographics, type and location of lesions, admission and discharge National Institutes of Health Stroke Scale (NIHSS), modified Ranken Scale (mRS) on discharge, radial artery diameter, device(s) used, anticoagulation, and complications. The median and interquartile range (IQR) were calculated for numerical data.

Patient and device selection criteria

All patients that presented were considered for radial access. The primary operator in this series (BP) had switched his neurointerventional practice to a radial-first approach in 2022, based on accumulating data that transradial neuroangiography and neurointervention is thought to be safer and preferred by most patients, especially in patients who require dual-antiplatelet therapy [11,12]. The decision to choose a ballon guide was driven by the possible benefit of proximal flow control in patients with cervical carotid artery stenosis, intracranial artery stenosis, or traumatic carotid artery injury [15,16].

Radial access and ballon guide catheter technique

Under sonographic guidance, the radial artery was accessed with a 22-gauge Angiocath needle using a double-wall puncture technique. The Angiocath was then exchanged over a 45 mm 0.021″ microwire or 0.018″ Nitrex wire (Medtronic, Minneapolis, MN, USA) for a 7-Fr Slender Glidesheath (Terumo, Tokyo, Japan). Next, approximately 15 mL of blood was aspirated into a 20 mL syringe containing 3000-5000 IU heparin, 100-200 mcg nitroglycerine, and 2.5 mg verapamil. The blood-medication mix was slowly injected into the radial artery. Next, under roadmap guidance, an exchange-length 0.035″ Glidewire advantage (Terumo, Tokyo, Japan) was advanced into the aortic arch, and the 7-Fr Slender Glidesheath was exchanged for a 90 cm Walrus BGC loaded with a 6-Fr 125 cm Simmons or VER catheter (Penumbra, Alameda, CA, USA). The Glidewire advantage was removed, and the Simmons catheter was reshaped in the descending aorta. The Simmons/VER catheter and a 0.035 Glidewire (Terumo, Tokyo, Japan) were then used to selectively catheterize the vessel of interest. The Walrus BGC was then tracked over the diagnostic catheter and/or Glidewire, depending on the patient’s anatomy, and positioned appropriately in the distal common carotid artery for carotid stenting, or in the distal cervical internal carotid artery for intracranial angioplasty/stenting. The Walrus BGC was inflated 1) during the initial crossing of the lesion with the microwire, 2) during balloon angioplasty/stent deployment, and 3) in case of cervical carotid stenting, while advancing the carotid stent from the access site to the site of stenosis. Approximately 10 mL of blood was briskly aspirated before balloon deflation. Carotid stenting or intracranial angioplasty/stenting was otherwise performed in the usual fashion with devices as seen in Table 1. Upon conclusion of the procedure, the Walrus BGC was removed, and a TR band was applied to achieve patent hemostasis.

RESULTS

Patient demographics

Thirteen patients underwent TRA carotid stenting (CAS) or intracranial angioplasty/stenting via a sheathless transradial approach with the Walrus BGC. Eight of the patients were male and the median age was 63 years (range 19-84, IQR 52-74 yrs).

Radial artery measurements

The mean radial artery diameter was 2.51 mm (SD 0.47, range 1.7-3.2 mm). No patients were excluded from attempting TRA based on preprocedural radial artery size measurements.

Procedural data

Procedures were all performed under general anesthesia with neuromonitoring as indicated. There were zero cases of TRA conversion to TFA. Median admission NIHSS was 2 (IQR 0-8), median discharge NIHSS was 1 (IQR 0-2) and median mRS was 1 (IQR 0-3). All interventions were successfully performed (Table 1).

Complications and post procedural data

There were zero cases of significant access site complications and no known ischemic complications of TRA. Mild swelling, ecchymosis, or pain at the puncture site was noted in a small number of patients, none of which required additional monitoring or intervention. No intraprocedural complications were encountered. Patient #10 suffered from post-operative thrombosis of the left internal carotid artery stent, and this resulted in a large left Middle Cerebral Artery (MCA) territory stroke with significant disability (mRS 5). Patients were evaluated between four- and six-week post procedure and then again at three months. At those time points, there were also no incidences of radial artery complications noted, although we did not obtain imaging to confirm radial artery patency.

Illustrative cases

Patient #3 (Fig. 1) presented with a symptomatic high-grade left Internal Cerebral Artery (ICA) stenosis. TRA was obtained with the sheathless 8F Walrus BGC following the technique outlined in the methods section. Initial angiographic images showed severe focal stenosis at the carotid bifurcation on the left. Prior to deployment of the distal embolic protection device (DEP), the ballon guide catheter was inflated and the stenosis crossed with the DEP wire followed by the DEP. The BGC was particularly helpful in this case as it served as an anchor point in torturous anatomy to prevent catheter prolapse into the aortic arch during delivery of the carotid stent (1F). The patient was discharged the next day with a NIHSS of 0.
Patient #7 (Fig. 2) presented with acutely symptomatic left ICA dissection that resulted in left cerebral hemisphere hypoperfusion. While the initial admission NIHSS was 3, the patient subsequently worsened to an NIHSS of 8 with severe aphasia and right arm plegia. The right radial artery was accessed as described above, and a cervical angiogram demonstrated left ICA dissection with an intramural thrombus resulting in occlusion of the left ICA. Again, the balloon was inflated prior to crossing the stenosis. No DEP could be used due to the location of the dissection extending into the horizontal petrous ICA segment. No intracranial large vessel occlusion was seen after the dissection site had been crossed with a microcatheter and microwire. The inflated balloon also provided additional support for subsequent stent reconstruction with a Surpass evolve 4×30 mm, Surpass evolve 4×25 mm, Onyx Frontier 4×22 mm Drug-eluting stent, and Acculink 6-8×30 mm carotid stent. Post stent angiogram demonstrated successful reconstruction of the left ICA with a widely patent stent construct spanning the entire length of the cervical ICA to the horizontal petrous segment, and no evidence of distal thrombo-embolic complication. The patient made an excellent recovery with a discharge NIHSS of 0 and a 90-day follow-up mRS of 0.

DISCUSSION

In summary, we report our experience with using the Walrus BGC via a sheathless transradial approach for carotid artery stenting and intracranial balloon angioplasty/stenting. We were able to successfully complete the procedure in all patients with zero vascular access or immediate target organ complications.
A common issue with TRA is that the radial artery is too small to allow for the placement of large catheter system, such as BGCs, that are used in the treatment of neuromuscular diseases. However, considering results from ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention that require antiplatelet therapy, TRA resulted in reduced vascular complications and improved overall survival [10,19]. Therefore, decreasing the diameter of the device entering the radial artery should allow for a transradial approach in patients who may not be able to tolerate the placement of an 8Fr sheath. Our patient cohort had a mean radial artery size of 2.51 mm, which is comparable to what has been reported in the literature [22], and the smallest radial diameter we were able to successfully access with this technique was only 1.7 mm. This suggests that this particular BGC can likely be used in the majority of patients. Furthermore, TRA should minimize access site bleeding complications, especially in patients who require antiplatelet therapy.
Utilizing a BGC for treatment of ischemic disease has three main advantages. First, balloon inflation allows for temporary flow arrest, which should minimize distal thromboembolic events, particularly with intracranial balloon angioplasty/stenting, where a DEP device cannot be used. Second, balloon inflation can be used to anchor the BGC in place (Fig. 1E and 2E), which prevents movement or even prolapse of the catheter construct into the aortic arch. This is particularly helpful for left carotid stenting from a right radial approach, considering the unfavorable anatomy and stiffness of currently available carotid stent systems. Third, when treating traumatic carotid injury (e.g., patient #9), balloon inflation can provide proximal control in case of intra-operative hemorrhage.
Additional advantages of TRA in neurointervention include aortic arch anatomy (e.g., bovine arch configuration with right radial to left carotid artery approach), or patients with common femoral artery (CFA) access difficulty including peripheral artery disease, prior CFA access, or prior stent or bypass involving the CFA. It is well established that TRA is superior to TFA regarding patient satisfaction, decreased access site complication, early ambulation and overall shortened length of patient stay [1,11].
In all cervical carotid artery stenting cases except for patient #7 (cervical and petrous ICA dissection that did not allow for DEP placement), a DEP was utilized as is standard-of-care at our center. For these patients, the BGC was utilized to potentially provide flow arrest during the initial crossing of the lesion, and to prevent catheter prolapse during stent delivery. While a detailed discussion of the evidence behind DEP is outside the scope of this report, it is noteworthy that the initial crossing of the stenotic segment is completed before the DEP device can be deployed. Arresting/reversing flow during this process may reduce the risk of distal emboli, though this study was not designed or powered to investigate this point. A large retrospective review has shown no significant difference in adverse events for BGC-mediate flow arrest versus DEP in transfemoral carotid stenting [14]. Moreover, Cappuzzo and colleagues [3] have demonstrated the safety of using the Walrus BGC to achieve flow arrest/reversal prior to crossing the stenotic segment in a series of 105 patients (DEP use in 85% of cases) without any periprocedural strokes or transient ischemic attacks.
Previous generations of BGC via TRA have been associated with an approximately 20% incidence of catheter kinking [15]. We did not experience any kinking with the Walrus catheter and in two other recent series of TRA BGC Walrus use (either sheathless or via a short 8-Fr sheath), no kinking was reported either [7,16]. Tracking the entire BGC through the radial artery could theoretically increase the risk of vasospasm and mechanical injury to the artery. We mitigated this risk by lubricating the balloon guide tip and shaft with saline and minimizing the movement of the BGC once in the correct position. In our opinion, the polyurethane balloon construction of Walrus BGC appears more robust than comparable contemporary BGCs. In both our series and Dossani et al. 2022 [7] (for a total of 22 patients), there were no instances of radial artery injury, severe vasospasm, or balloon damage with the use of this technique.
As with many aspects of the rapidly advancing neurointerventional field, the lack of direct comparison studies limits definitive conclusions. For example, there are no direct comparison studies between contemporary BGCs [23], and no randomized data that establishes BGC superiority over other techniques for stroke thrombectomy [8]. Retrospective registry studies point to a benefit of BGCs for thrombectomy, but heterogeneity in technique and BGC positioning may have affected the outcomes of these studies [9,13,18,21]. Fortunately, at least one RCT (proFATE) is currently underway in the UK, which should help answer some of these questions [6]. In a single-arm study, the Walrus BGC was safe and effective in stroke thrombectomy with high reperfusion rates [5]. Baig and colleagues have recently shown a benefit of Walrus in patients undergoing urgent carotid stenting for tandem strokes [2]. Since sheathless TRA of contemporary BGCs other than Walrus has not been reported, our study cannot provide comparative data. Furthermore, the low incidence of thromboembolic complications with carotid stenting also generally precludes single-center studies of technical nuances, device use, and access routes. Additional limitations of this study include its limited sample size and retrospective design. While no immediate access site complications were found, we did not follow patients for longer than 3 months to know if there were any delayed ischemic complications with TRA nor obtain any follow-up imaging of the radial artery to assess patency.

CONCLUSIONS

The Walrus 0.087″ ID BGC is an effective tool that can safely be used via the radial artery using a sheathless approach which helps to maximize the size of the catheter that can be used. This is the first instance to our knowledge of this technique being utilized for neurointerventions other than stroke thrombectomy and therefore could be used to expand the indications for TRA to a wider range of procedures.

NOTES

Disclosure

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Fig. 1.
Patient #3 with symptomatic high-grade left internal carotid artery stenosis. (A) Roadmap angiogram of the right radial artery after access. (B-C) Walrus catheter tracking over the wire within the common carotid artery (yellow arrows) and advancement to final position. (D) Pretreatment angiogram of the left common carotid artery, yellow arrows showing the site of severe focal stenosis at the carotid bifurcation. (E) Inflated balloon as the lesion is crossed with the microwire to minimize thromboembolic events. (F) Balloon used as anchor during stent advancement to prevent balloon guide catheter prolapse into the aortic arch. (G) Post intervention angiogram of the left common carotid artery demonstrates no significant residual stenosis after stent placement.
jcen-2024-e2024-05-003f1.jpg
Fig. 2.
Patient #7 with acutely symptomatic left internal carotid dissection. (A-B) Walrus catheter tracking within the left common carotid artery over the diagnostic catheter and wire. (C) Left common carotid angiogram demonstrates left ICA dissection with intramural thrombus resulting in occlusion of the left Internal Carotid Artery (ICA). (D) Pretreatment angiogram of left ICA circulation demonstrates no intracranial large vessel occlusion. (E) Walrus catheter inflation to increase the stability of the balloon guide catheter for stent delivery and deployment. (F) Native view of stent construct. (G, H) Post treatment left common carotid angiogram demonstrates widely patent stent construct with reconstitution of left ICA, no significant residual stenosis, and brisk intracranial flow without distal thromboembolic complication.
jcen-2024-e2024-05-003f2.jpg
Table 1.
Patient cohort, outcomes, and case logs
Patient # Age Sex Diagnosis Anesthesia Radial access Radial artery diameter TRA to TFA Treatment technique and site Device(s) used Preprocedural antiplatelet agents Admission NHISS Discharge NIHSS mRS Complications
1 84 M Symptomatic left middle cerebral artery M1 segment stenosis General Right 3.1 mm No Intracranial balloon angioplasty and stenting of L M1 stenosis (1) NC TREK 1.5×6 mm balloon; (2) Onyx Frontier 2×12 mm DES Heparin, Integrillin 11 3 3 None
2 52 F Symptomatic right cavernous internal carotid stenosis General Right 2.1 mm No Balloon angioplasty of right internal cavernous segment of carotid artery (1) NC Euphora 3×12 mm balloon Heparin, Aspirin, Plavix 0 0 0 None
3 63 F Symptomatic left cervical carotid stenosis General Right 2.3 mm No Left internal carotid artery balloon angioplasty and stenting (1) XACT 6-8×40 mm carotid stent; (2) Emboshield NAV6 Heparin, Aspirin, Plavix 0 0 0 None
4 78 M Symptomatic right cervical carotid stenosis General Right 2.9 mm No Right internal carotid artery balloon angioplasty and stenting (1) XACT 7-9×40 mm carotid stent; (2) Emboshield NAV6 Heparin, Aspirin, Plavix 0 0 0 None
5 73 M Symptomatic left cervical carotid stenosis General Right n/a No Left internal carotid artery balloon angioplasty and stenting (1) XACT 6-8×40 mm carotid stent; (2) Emboshield NAV6 Heparin, Aspirin, Plavix 8 9 3 None
6 77 M Symptomatic left intracranial internal carotid stenosis General Right 3.2 No Balloon angioplasty of left supraclinoid internal carotid artery NC Euphora 2.5×12 mm balloon Heparin, Aspirin, Plavix 3 3 1 None
7 43 F Symptomatic left cervical internal carotid dissection with underlying fibromuscular dysplasia General Right 1.7 No Stent reconstruction of dissected left cervical and petrous internal carotid artery segments (1) Surpass evolve 4×30 mm; (2) Surpass evolve 4×25 mm; (3) Onyx Frontier 4×22 mm DES; (4) Acculink 6-8×30 mm carotid stent Heparin, Integrillin, Aspirin 3 0 0 None
8 54 M Symptomatic right cervical carotid stenosis General Right 2.7 No Right internal carotid artery balloon angioplasty and stenting (1) Acculink 6-8×30 mm carotid stent; (2) Emboshield NAV6 Heparin, Aspirin, Plavix 1 1 1 None
9 19 M Traumatic cavernous internal carotid artery injury with enlarging pseudoaneurysm General Right 2.6 No Covered stent reconstruction of cavernous and ophthalmic segments of right carotid artery PK Papyrus 3.5×20 mm covered balloon-mounted stent Heparin, Integrillin 0 0 1 None
10 63 F Symptomatic left petro-cavernous internal carotid artery stenosis General Right 2.2 No Intracranial balloon angioplasty and stenting of left ICA stenosis, (1) NC Euphora 3×15 mm balloon; (2) Onyx Frontier 3×22 mm DES Heparin, Aspirin, Plavix 3 28 5 Post-operative in-stent thrombosis resulting in large left MCA territory ischemic stroke
11 70 F Symptomatic right middle cerebral artery M1 segment stenosis General Right 1.9 No Intracranial balloon angioplasty and stenting of R M1 stenosis (1) NC Euphora 1.5×12 mm balloon; (2) Onyx Frontier 2×8 mm DES Heparin, Aspirin, Plavix 5 1 1 None
12 74 M Asymptomatic right cervical internal carotid artery stenosis General Right 2.7 No Right internal carotid artery balloon angioplasty and stenting (1) Xact 8-10×40 mm carotid stent; (2) Emboshield NAV6 Heparin, Aspirin, Plavix 0 0 0 None
13 52 M Symptomatic left cervical internal carotid artery stenosis General Right 2.7 No Left internal carotid artery balloon angioplasty and stenting (1) Xact 6-8×30 mm carotid stent; (2) Viatrac 14 5×20 mm balloon; (3) Emboshield NAV6 Heparin, Aspirin, Plavix 0 0 0 None

REFERENCES

1. Al Halabi S, Burke L, Hussain F, Lopez J, Mathew V, Bernat I, et al. Radial versus femoral approach in women undergoing coronary angiography: a meta-analysis of randomized controlled trials. J Invasive Cardiol. 2019 Nov;31(11):335-40.
pmid
2. Baig AA, Waqas M, Turner RC, Kuo CC, Donnelly BM, Lai PMR, et al. A propensity score-matched comparative study of balloon guide catheters versus conventional guide catheters for concurrent mechanical thrombectomy with carotid stenting in tandem strokes: comparison of first pass effect, symptomatic intracranial hemorrhage, and 90-day functional outcomes. J Neurointerv Surg. 2024 Jan;16(2):124-30.
crossref pmid
3. Cappuzzo JM, Monteiro A, Waqas M, Baig AA, Popoola DO, Almayman F, et al. Carotid artery stenting using the Walrus balloon guide catheter with flow reversal for proximal embolic protection: technical description and single-center case series. Oper Neurosurg (Hagerstown). 2023 Jan;24(1):11-6.
crossref pmid
4. Chen SH, Peterson EC. Radial access for neurointervention: room set-up and technique for diagnostic angiography. J Neurointerv Surg. 2021 Jan;13(1):96.
crossref pmid
5. Cortez GM, Turner RD, Monteiro A, Puri AS, Siddiqui AH, Mocco J, et al. Walrus large bore guide catheter impact on recanalization first pass effect and outcomes: the WICkED study. J Neurointerv Surg. 2022 Mar;14(3):280-5.
crossref pmid
6. Dhillon PS, Butt W, Podlasek A, Bhogal P, McConachie N, Lenthall R, et al. Effect of proximal blood flow arrest during endovascular thrombectomy (ProFATE): Study protocol for a multicentre randomised controlled trial. Eur Stroke J. 2023 Jun;8(2):581-90.
crossref pmid pmc pdf
7. Dossani RH, Waqas M, Monteiro A, Cappuzzo JM, Almayman F, Snyder KV, et al. Use of a sheathless 8-French balloon guide catheter (Walrus) through the radial artery for mechanical thrombectomy: technique and case series. J Neurointerv Surg. 2022 May;14(5):neurintsurg-2021-017868.
crossref pmid
8. Goyal M, Kappelhof M, Ospel JM, Bala F. Balloon guide catheters: use, reject, or randomize? Neuroradiology. 2021 Aug;63(8):1179-83.
crossref pmid pdf
9. Jeong DE, Kim JW, Kim BM, Hwang W, Kim DJ. Impact of balloon-guiding catheter location on recanalization in patients with acute stroke treated by mechanical thrombectomy. American Journal of Neuroradiology. 2019 May;40(5):840-4.
crossref pmid pmc
10. Joyal D, Bertrand OF, Rinfret S, Shimony A, Eisenberg MJ. Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol. 2012 Mar;109(6):813-8.
crossref pmid
11. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009 Jan;157(1):132-40.
crossref pmid
12. Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011 Apr;377(9775):1409-20.
pmid
13. Knapen RRMM, Goldhoorn RB, Hofmeijer J, Lycklamaà Nijeholt GJ, van den Berg R, van den Wijngaard IR, et al. Balloon guide catheter versus non-balloon guide catheter: A MR CLEAN registry analysis. Stroke: Vascular and Interventional Neurology. 2024 Jul;4(4):e001103.
crossref
14. Liang P, Soden P, Wyers MC, Malas MB, Nolan BW, Wang GJ, et al. The role of transfemoral carotid artery stenting with proximal balloon occlusion embolic protection in the contemporary endovascular management of carotid artery stenosis. J Vasc Surg. 2020 Nov;72(5):1701-10.
crossref pmid
15. Martínez-Galdámez M, Schüller M, Galvan J, de Lera M, Kalousek V, Ortega-Gutierrez S, et al. Safety and feasibility of transradial use of 8F balloon guide catheter Flowgate2 for endovascular thrombectomy in acute ischemic stroke. Interv Neuroradiol. 2022 Feb;28(1):22-8.
crossref pmid pdf
16. Moldovan K, Yaeger KA, Al-Kawaz M, Scaggiante J, Kellner CP, De Leacy R, et al. Transradial Carotid Artery Stenting Using Walrus Balloon Guide Catheter: Technical Aspects and Clinical Outcome. Oper Neurosurg (Hagerstown). 2023 Jul;25(1):28-32.
crossref pmid
17. Patel P, Haussen DC, Nogueira RG, Khandelwal P. The Neuro Radialist. Interv Cardiol Clin. 2020 Jan;9(1):75-86.
crossref pmid
18. Pederson JM, Hardy N, Lyons H, Sheffels E, Touchette JC, Brinjikji W, et al. Comparison of balloon guide catheters and standard guide catheters for acute ischemic stroke: An updated systematic review and meta-analysis. World Neurosurgery. 2024 May;185:26-44.
crossref pmid
19. Saito S, Ikei H, Hosokawa G, Tanaka S. Influence of the ratio between radial artery inner diameter and sheath outer diameter on radial artery flow after transradial coronary intervention. Catheter Cardiovasc Interv. 1999 Feb;46(2):173-8.
crossref pmid
20. Snelling BM, Sur S, Shah SS, Khandelwal P, Caplan J, Haniff R, et al. Transradial cerebral angiography: techniques and outcomes. J Neurointerv Surg. 2018 Sep;10(9):874-81.
crossref pmid
21. Velasco A, Buerke B, Stracke CP, Berkemeyer S, Mosimann PJ, Schwindt W, et al. Comparison of a balloon guide catheter and a non-balloon guide catheter for mechanical thrombectomy. Radiology. 2016 Jul;280(1):169-76.
crossref pmid
22. Wahood W, Ghozy S, Al-Abdulghani A, Kallmes DF. Radial artery diameter: a comprehensive systematic review of anatomy. J Neurointerv Surg. 2022 Dec;14(12):1274-8.
crossref pmid
23. Yi HJ, Lee DH, Sung JH. Comparison of FlowGate2 and Merci as balloon guide catheters used in mechanical thrombectomies for stroke intervention. Experimental and Therapeutic Medicine. 2020 Aug;20(2):1129-36.
crossref pmid pmc
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 501 View
  • 22 Download
ORCID iDs

Benjamin Pulli
https://orcid.org/0000-0002-1795-9897

Related articles


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
The Journal of Cerebrovascular and Endovascular Neurosurgery (JCEN), Department of Neurosurgery, Wonkwang University
School of Medicine and Hospital, 895, Muwang-ro, Iksan-si, Jeollabuk-do 54538, Korea
Tel: +82-2-2279-9560    Fax: +82-2-2279-9561    E-mail: editor.jcen@the-jcen.org                

Copyright © 2025 by Korean Society of Cerebrovascular Surgeons and Korean NeuroEndovascular Society.

Developed in M2PI

Close layer
prev next